Navigation thread
Navigation thread
Osteoporosis
Make a donation
Make a donation
Joint project with . This link opens in a new tab.

Research lines of Osteoporosis

Reading time: 1 min

Various studies are currently being carried out with new treatments for osteoporosis, but they are all still in an experimental phase.

Studies in more advanced stages and with more promising results are those focusing on the protein related to the parathyroid hormone (PTHrP) and treatment with anti-sclerostin monoclonal antibodies. 

Treatments with PTHrP and anti-sclerostin monoclonal antibodies both have an impact on bone-forming cells (osteoblasts). 

Read more Frequently Asked Questions
Joint project with . This link opens in a new tab.

Substantiated information by:

Celia Saura Demur
Núria Guañabens Gay
Pilar Peris Bernal

Published: 20 February 2018
Updated: 20 February 2018

The donations that can be done through this webpage are exclusively for the benefit of Hospital Clínic of Barcelona through Fundació Clínic per a la Recerca Biomèdica and not for BBVA Foundation, entity that collaborates with the project of PortalClínic.

Subscribe

Receive the latest updates related to this content.

Thank you for subscribing!

If this is the first time you subscribe you will receive a confirmation email, check your inbox

An error occurred and we were unable to send your data, please try again later.